2-{2-oxo-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-5-yl}acetic acid
Structure Info
- Chemspace ID
- CSSS00000023187 (In-Stock Screening Compounds)
- CAS
- 55453-87-7, 27833-64-3
- MFCD
- MFCD00242952, MFCD13196014
- IUPAC Name
- 2-{2-oxo-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-5-yl}acetic acid
- Mol formula
- C16H12O4
- Mol weight
- 268 Da
- Catalog Number(s)
- 37817, 45012, 329406, 55453-87-7, A276039, AA003A6G, AB53060, AC005039, ACDS-036787, ACM55453877, ADB65201001, AG003A98, AJ53060, AK01258, AOS003A98, APB55453877, APS55453877, AR003AY8, ArZ-UP061975, ArZ-UP355910, BBV-398412839, BD16257, BUP18108, C47475, CD33000236, CS-0031651, CSC000023187, CT1317, D4242, D954898, D961643, EN300-18552809, F036537, FI24735, HY-W050088, I917700, J10871, J11576, J52055, JH700146, K43573, LAN-B35609, LN00174124, LQT-B35674, M27889, N759, OR1011950, Q-100635, R247555, S5044, SAB-024053, SC-13485, SY051246, T27635, TS-03511, Z2681893145, ZX-AE001676, ZXC096923
- Dangerous substance
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.66
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.125
- Polar surface area (Å)
- 64
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00000023187
Items Overall 18 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 500 mg | 50 | |
| MedChemExpress | 10 days | United States To: | 99 | 1 g | 70 | |
| MedChemExpress | 10 days | United States To: | 99 | 5 g | 140 | |
| MedChemExpress | 10 days | United States To: | 99 | 1 ml | 55 | |
Description: Names: Isoxepac; HP 549; Product Description: Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases; Target: Drug Derivative; CAS: 55453-87-7 | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 500 mg | 50 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 1 g | 70 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 g | 140 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 1 ml | 55 | |
Description: Names: Isoxepac; HP 549; Product Description: Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases; Target: Drug Derivative; CAS: 55453-87-7 | ||||||
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 90 | 1 mg | 53.9 | |
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 90 | 5 mg | 62.7 | |
| Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 90 | 10 mg | 77 | |
| Enamine Ltd. | 15 days | Ukraine To: | 90 | 50 mg | 21 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 200 mg | 30 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 500 mg | 41 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 1 g | 56 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 2 g | 80 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 g | 129 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 10 g | 189 | |
Description: Isoxepac (Olopatadine USP Related Compound C) is a non-steroidal anti-antiphlogistic agent and analgesic.; CAS: 55453-87-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire